|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/395 | (2006.01) |
| A61K2039/505 | (2013.01) | ||
| C07K 16/28 | (2006.01) | ||
| A61K2039/545 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| C07K 16/2803 | (2013.01) | ||
| C07K2317/24 | (2013.01) |
| (11) | Number of the document | 3442578 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17783254.0 |
| Date of filing the European patent application | 2017-04-14 | |
| (97) | Date of publication of the European application | 2019-02-20 |
| (45) | Date of publication and mention of the grant of the patent | 2022-02-09 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2017/027662 |
| Date | 2017-04-14 |
| (87) | Number | WO 2017/181033 |
| Date | 2017-10-19 |
| (30) | Number | Date | Country code |
| 201662323330 P | 2016-04-15 | US | |
| 201662427679 P | 2016-11-29 | US |
| (72) |
WEISSMAN, Irving L. , US
CHAO, Mark P. , US
MAJETI, Ravindra , US
LIU, Jie , US
VOLKMER, Jens-Peter , US
|
| (73) |
The Board of Trustees of the Leland Stanford
Junior University ,
Office of the General Counsel
Building 170, Third Floor, Main Quad
P.O. Box 20386, Stanford, CA 94305-2038,
US
|
| (54) | METHODS FOR DETERMINING AND ACHIEVING THERAPEUTICALLY EFFECTIVE DOSES OF ANTI-CD47 AGENTS IN TREATMENT OF CANCER |
| METHODS FOR DETERMINING AND ACHIEVING THERAPEUTICALLY EFFECTIVE DOSES OF ANTI-CD47 AGENTS IN TREATMENT OF CANCER |